24.07.2017 17:00:00

Diplomat to Release Second Quarter 2017 Operating Results and Host Conference Call on Monday, August 7, 2017

FLINT, Mich., July 24, 2017 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO) announced today that it will release its second quarter 2017 operating results on Monday, August 7, 2017 after market close, with a conference call to follow at 5:00 p.m. ET.

Diplomat Specialty Pharmacy (PRNewsFoto/Diplomat Pharmacy, Inc.)

Shareholders and interested participants may listen to a live broadcast of the conference call by dialing 877-201-0168 or 647-788-4901 for international callers, and referencing participant code 51641230 approximately 15 minutes prior to the call. A live webcast of the conference call will be available on the investor relations section of the Company's website and an audio file of the call, as well as supplemental investor information, will be available for 90 days at ir.diplomat.is.

About Diplomat

Diplomat (NYSE: DPLO) is the nation's largest independent provider of specialty pharmacy services—helping patients and providers in all 50 states. The company offers medication management programs for people with complex chronic diseases and delivers unique solutions for manufacturers, hospitals, payors, providers, and more. Diplomat opened its doors in 1975 as a neighborhood pharmacy with one essential tenet: "Take good care of patients and the rest falls into place." Today, that tradition continues—always focused on improving patient care and clinical adherence. For more information visit diplomat.is.

INVESTOR CONTACT:

Bob East, Westwicke Partners
443.213.0500 | diplomat@westwicke.com

MEDIA CONTACT:

Jenny Cretu, Diplomat
810.768.9370 | jcretu@diplomat.is

View original content with multimedia:http://www.prnewswire.com/news-releases/diplomat-to-release-second-quarter-2017-operating-results-and-host-conference-call-on-monday-august-7-2017-300492802.html

SOURCE Diplomat Pharmacy, Inc.

Nachrichten zu Diplomat Pharmacy Incmehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu Diplomat Pharmacy Incmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!